Mechanisms of the androgen receptor splicing in prostate cancer cells.
about
Splice Variants of Androgen Receptor and Prostate CancerUnderstanding prostate-specific antigen dynamics in monitoring metastatic castration-resistant prostate cancer: implications for clinical practiceEmerging mechanisms of resistance to androgen receptor inhibitors in prostate cancerBiologic and clinical significance of androgen receptor variants in castration resistant prostate cancerNovel Insights into Molecular Indicators of Response and Resistance to Modern Androgen-Axis Therapies in Prostate CancerEmerging data on androgen receptor splice variants in prostate cancerThe RNA-binding protein Sam68 regulates expression and transcription function of the androgen receptor splice variant AR-V7TALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer.The link between androgen receptor splice variants and castration-resistant prostate cancer.Splicing variants of androgen receptor in prostate cancer.Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy.Molecular characterization of enzalutamide-treated bone metastatic castration-resistant prostate cancerConstitutive activity of the androgen receptor.Complex impacts of PI3K/AKT inhibitors to androgen receptor gene expression in prostate cancer cells.20(S)-protopanaxadiol inhibition of progression and growth of castration-resistant prostate cancer.Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapiesLessons from tissue compartment-specific analysis of androgen receptor alterations in prostate cancer.Androgen Receptor Splice Variants Dimerize to Transactivate Target Genes.Role of BioResponse 3,3'-Diindolylmethane in the Treatment of Human Prostate Cancer: Clinical Experience.Cotargeting Androgen Receptor Splice Variants and mTOR Signaling Pathway for the Treatment of Castration-Resistant Prostate CancerEdelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor ActivityAn imaging agent to detect androgen receptor and its active splice variants in prostate cancerAcquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer.Molecular pathways: targeting resistance in the androgen receptor for therapeutic benefitMechanisms of androgen receptor activation in castration-resistant prostate cancerNovel Nine-Exon AR Transcripts (Exon 1/Exon 1b/Exons 2-8) in Normal and Cancerous Breast and Prostate Cells.Systematic and functional characterization of novel androgen receptor variants arising from alternative splicing in the ligand-binding domain.The non-coding transcriptome as a dynamic regulator of cancer metastasisAR-v7 protein expression is regulated by protein kinase and phosphatase.Precision medicine for prostate cancer.Decoding the androgen receptor splice variants.FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer.Are androgen receptor variants a substitute for the full-length receptor?Overview on the complexity of androgen receptor-targeted therapy for prostate cancerProstate stromal cells express the progesterone receptor to control cancer cell mobility.Emerging drugs for the treatment of bone metastasis.Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9(®) to Suppress Enzalutamide-resistant Prostate Cancer Progression.Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studies.The Y-located proto-oncogene TSPY exacerbates and its X-homologue TSPX inhibits transactivation functions of androgen receptor and its constitutively active variants.Multivalent Peptoid Conjugates Which Overcome Enzalutamide Resistance in Prostate Cancer Cells.
P2860
Q26740592-0750BE7F-932E-4B02-83C4-3960EBCF53F0Q26748538-149AFDB9-63EC-4F85-912B-C25FC2ED406FQ26777310-94E4B24A-D80A-4A82-94B4-107A6644ECD9Q26858922-58EA31CC-2774-4EE9-B4FE-203CC5BF50DDQ28067556-02A95680-14D7-40F8-9D02-F6F54A08E482Q28077830-88E23D9F-4A74-4339-88AC-B89A344A2121Q30370955-44BECA97-262C-436C-AACC-F0057D789B92Q30554439-B0088DA7-CC22-416A-98D2-6DAD717540E8Q30618562-7A43A8DB-50B6-4E8D-8B30-347C9B4A6FECQ34448143-DB716550-370A-44AF-973A-D3374E6BDAB0Q34528225-8010A2D2-2F0B-480A-B5F0-90962D269F47Q34587744-B00E19CE-1ED3-4A62-B415-204F5A7EC4EEQ34775572-F24A901D-024E-499C-B07A-033406053D6BQ35382353-C78DAF65-3937-4CBC-B921-EA5AA181E5A7Q35399276-4338FDEF-1B1A-4B09-BC06-45426F3CB73CQ35842471-E206B352-2A18-48FD-A9A4-2D1E75A0C593Q36004694-5E19A80C-7A9A-4257-AB35-E05B7D680A32Q36021859-889F010A-1B60-43DB-BE62-D362310F894FQ36844904-7AEC3B08-3C4F-4146-BBD8-C44AC6C13956Q36963697-28E06CB2-4495-4F75-9BA8-8AC57F90B442Q37066598-7780E3C8-AFB8-4B69-910B-BA5080853A93Q37165574-43D68461-332E-4550-B2F2-476D36B72AE2Q37295639-E9B2213D-9EBE-4932-A137-27477A0013EEQ37620953-F00C080D-59DF-47E1-8613-138AF7DB07D4Q37628940-9AE039F9-4357-4AF4-8D0C-7B1D051CDD4DQ37631437-ECEAAC6F-73D6-4105-ABCD-F9F3A8943B5AQ37691775-EAA872B5-9F28-4C6D-BC87-02B6745FD2C0Q37705696-D8CE6C4F-A157-4697-A321-F175856218DBQ38261421-B96CB783-548B-481A-86ED-A62EFFE3B50CQ38263711-BCB22152-419D-46D8-9E77-60AB65F28461Q38263870-B535DBD5-3D76-483E-AF5D-3215EAC93C64Q38286227-972E84B5-D1A2-4025-A1E5-44B1EE2D4C67Q38350089-28BCD231-35F5-489D-8158-C8B6BA52DFD7Q38364166-E3959FE6-C7B1-42C1-9F92-B168FD63C7DDQ38447554-7DC7FEEF-D9E2-496C-B143-CCEF41E0BA81Q38538263-0901FBD7-C8D9-4827-B796-76DC4E6911BCQ38681329-6E472F4F-EBEA-4801-A600-86DDB20DAA0BQ38700661-B4F29B60-62D2-40D3-86F7-3AC44A7C6A81Q38717520-9BBB00A6-1669-4F20-B4B1-629E6C452707Q38753981-946CDCEA-4A37-43ED-BCBF-9A995B79D8D8
P2860
Mechanisms of the androgen receptor splicing in prostate cancer cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Mechanisms of the androgen receptor splicing in prostate cancer cells.
@ast
Mechanisms of the androgen receptor splicing in prostate cancer cells.
@en
type
label
Mechanisms of the androgen receptor splicing in prostate cancer cells.
@ast
Mechanisms of the androgen receptor splicing in prostate cancer cells.
@en
prefLabel
Mechanisms of the androgen receptor splicing in prostate cancer cells.
@ast
Mechanisms of the androgen receptor splicing in prostate cancer cells.
@en
P2093
P2860
P356
P1433
P1476
Mechanisms of the androgen receptor splicing in prostate cancer cells.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2013.284
P407
P577
2013-07-15T00:00:00Z